Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.
Harzic
Martine
M
Service de Microbiologie, Centre Hospitalier de Versailles, Le Chesnay, France.
Pellegrin
Isabelle
I
Deveau
Christiane
C
Chaix
Marie-Laure
ML
Dubeaux
Béatrice
B
Garrigue
Isabelle
I
Ngo
Nicole
N
Rouzioux
Christine
C
Goujard
Cécile
C
Hoen
Bruno
B
Sereni
Daniel
D
Delfraissy
Jean-François
JF
Meyer
Laurence
L
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D015331:Cohort Studies; D024882:Drug Resistance, Viral / Q000235:genetics*; D005260:Female; D005602:France; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D016333:HIV Protease / Q000235:genetics*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D012367:RNA, Viral; D019438:Ritonavir / Q000627:therapeutic use; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use
D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D054303:HIV Reverse Transcriptase; D016333:HIV Protease; D019438:Ritonavir